rs199929811
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001379610.1(SPINK1):c.88-23A>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00273 in 1,561,578 control chromosomes in the GnomAD database, including 8 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). There are indicators that this mutation may affect the branch point..
Frequency
Consequence
NM_001379610.1 intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SPINK1 | NM_001379610.1 | c.88-23A>T | intron_variant | ENST00000296695.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SPINK1 | ENST00000296695.10 | c.88-23A>T | intron_variant | 1 | NM_001379610.1 | P1 | |||
SPINK1 | ENST00000510027.2 | c.88-23A>T | intron_variant | 3 | |||||
SPINK1 | ENST00000505722.1 | upstream_gene_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.00208 AC: 316AN: 152162Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00246 AC: 590AN: 239486Hom.: 1 AF XY: 0.00256 AC XY: 331AN XY: 129490
GnomAD4 exome AF: 0.00280 AC: 3945AN: 1409298Hom.: 8 Cov.: 22 AF XY: 0.00280 AC XY: 1970AN XY: 703776
GnomAD4 genome AF: 0.00208 AC: 316AN: 152280Hom.: 0 Cov.: 32 AF XY: 0.00188 AC XY: 140AN XY: 74472
ClinVar
Submissions by phenotype
Hereditary pancreatitis Benign:4
Benign, criteria provided, single submitter | clinical testing | KCCC/NGS Laboratory, Kuwait Cancer Control Center | Jul 07, 2023 | - - |
Benign, criteria provided, single submitter | curation | Sema4, Sema4 | Feb 26, 2020 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 31, 2020 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 20, 2022 | - - |
not provided Benign:3
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Oct 31, 2023 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics | May 22, 2017 | - - |
Hereditary pancreatitis;C1842402:Tropical pancreatitis Benign:1
Benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | May 23, 2022 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at